𝔖 Bobbio Scriptorium
✦   LIBER   ✦

O-089 ERCC1 mRNA-based randomized phase III trial of docetaxel (doc) doublets with cisplatin (cis) or gemcitabine (gem) in stage IV non-small-cell lung cancer (NSCLC) patients (p)

✍ Scribed by Cobo, M.; Isla, D.; Sánchez, J.; Massuti, B.; Montes, A.; Paz-Ares, L.; Múñoz, M.; Viñolas, N.; Lopez-Vivanco, G.; Felip, E.


Book ID
118572637
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
131 KB
Volume
49
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES